{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:48:43Z","timestamp":1745992123860,"version":"3.37.3"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0199140","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T13:28:42Z","timestamp":1529328522000},"page":"e0199140","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4757-9956","authenticated-orcid":true,"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Souberbielle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Deleaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie","family":"Lorriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Marc","family":"Hurot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolie","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ndt\/gfs404","article-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?","volume":"28","author":"D Fouque","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","first-page":"1737","article-title":"Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country&apos;s healthcare expenditure and nephrologist workforce?","volume":"32","author":"S Liabeuf","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","first-page":"222","article-title":"The frequency of bone fractures among patients with chronic kidney disease not on dialysis: two-year follow-up","volume":"55","author":"A Figurek","year":"2017","journal-title":"Rom J Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000334424","article-title":"Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients","volume":"120","author":"G Jean","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"F Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease","volume":"21","author":"M Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref7","first-page":"S1","article-title":"KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Q Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"ref9","first-page":"F253","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"M Rodriguez","year":"2005"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/j.jrn.2011.09.006","article-title":"Keto acid therapy in predialysis chronic kidney disease patients: final consensus","volume":"22","author":"M Aparicio","year":"2012","journal-title":"J Ren Nutr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ndt\/gfs119","article-title":"Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone","volume":"28","author":"G Jean","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.ajkd.2011.08.033","article-title":"Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial","volume":"59","author":"C Basile","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12882-016-0365-9","article-title":"Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients","volume":"17","author":"G Jean","year":"2016","journal-title":"BMC Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gft275","article-title":"Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts","volume":"29","author":"P Delanaye","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP68063","article-title":"12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers","volume":"68","author":"G Jean","year":"2007","journal-title":"Clin Nephrol"},{"key":"ref16","first-page":"154","article-title":"Crosslaps?","volume":"9","author":"G Jean","year":"2013","journal-title":"Bone biomarkers in haemodialysis patients: Bone alkaline phosphatase or ss-"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1038\/s41598-017-12808-3","article-title":"Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients","volume":"7","author":"P Delanaye","year":"2017","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what&apos;s changed and why it matters","volume":"92","author":"M Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"EW Young","year":"2005","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"GM Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: Implication for the care of CKD patients","volume":"70","author":"JC Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"c112","DOI":"10.1159\/000081552","article-title":"Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients","volume":"98","author":"H Reichel","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11255-015-0917-0","article-title":"A correlation between decreased parathyroid alpha-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients","volume":"47","author":"J Yan","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/sdi.12411","article-title":"Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease","volume":"28","author":"AJ Felsenfeld","year":"2015","journal-title":"Seminars in dialysis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials","volume":"6","author":"P Kandula","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"SA Jamal","year":"2013","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ki.2011.226","article-title":"No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial","volume":"80","author":"D Hansen","year":"2011","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"LD Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref29","first-page":"S62","article-title":"Parathyroidectomy in chronic renal failure: indications, surgical approach and the use of calcitriol","volume":"29","author":"F Llach","year":"1990","journal-title":"Kidney Int Suppl"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"O Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref31","first-page":"470","article-title":"Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe","volume":"13","author":"G Jean","year":"2017","journal-title":"Nephrol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"A Lishmanov","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"CP Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1185\/03007990802437943","article-title":"Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients","volume":"24","author":"GT Schumock","year":"2008","journal-title":"Curr Med Res Opin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0199140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:23:36Z","timestamp":1540261416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0199140"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0199140","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,6,18]]}}}